Old Mutual Customised Solutions’s United Therapeutics UTHR Stock Holding History

Old Mutual Customised Solutions’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$45K	Hold	400	–	–	﹤0.01%	742
2018 Q1	$45K	Hold	400	–	–	﹤0.01%	725
2017 Q4	$59K	Hold	400	–	–	0.01%	716
2017 Q3	$47K	Hold	400	–	–	0.01%	762
2017 Q2	$52K	Hold	400	–	–	0.01%	743
2017 Q1	$54K	Hold	400	–	–	0.01%	749
2016 Q4	$57K	Buy	+400	New	+$51.1K	0.01%	753
2013 Q3	–	Sell	-400	Closed	-$26K	–	1225
2013 Q2	$26K	Buy	+400	New	+$25.8K	0.01%	1038

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Old Mutual Customised Solutions's UTHR Position: Q2 2018 in Review

Old Mutual Customised Solutions held its United Therapeutics (UTHR) position steady in Q2 2018 at 400 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #742.

Old Mutual Customised Solutions first reported a position in UTHR in Q2 2013 and has held it in 8 quarters since. The position peaked at $59K in Q4 2017. 374 funds tracked by Wall St. Rank hold UTHR as of Q2 2018.

Old Mutual Customised Solutions held 400 shares of United Therapeutics worth $45K as of Q2 2018.
Old Mutual Customised Solutions left its United Therapeutics share count unchanged in Q2 2018.
United Therapeutics made up ﹤0.01% of Old Mutual Customised Solutions's portfolio in Q2 2018, its #742 holding.
Old Mutual Customised Solutions first reported a position in United Therapeutics in Q2 2013 and has held it in 8 quarters since.
Old Mutual Customised Solutions's United Therapeutics position peaked at $59K in Q4 2017.
374 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2018.

Based on Old Mutual Customised Solutions's 13F filing for Q2 2018, filed 14 Aug 2018.